Furthermore, differential quantitative proteomic analysis of patients with PCa and benign prostatic hyperplasia (BPH) showed a significant decrease in FKBP5, FAM129A, RAB27A, FASN, NEFH proteins after local PCa treatment. The gene discussed is FASN; the disease is benign prostatic hyperplasia.